Compare KZIA & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KZIA | UGRO |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | Australia | United States |
| Employees | 6 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.4M | 3.0M |
| IPO Year | 1999 | N/A |
| Metric | KZIA | UGRO |
|---|---|---|
| Price | $6.68 | $0.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $17.67 | $3.00 |
| AVG Volume (30 Days) | 251.9K | ★ 13.7M |
| Earning Date | 12-26-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,199,108.00 | ★ $59,985,138.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $28.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.86 | $0.21 |
| 52 Week High | $17.40 | $1.17 |
| Indicator | KZIA | UGRO |
|---|---|---|
| Relative Strength Index (RSI) | 42.16 | 47.44 |
| Support Level | $5.30 | $0.28 |
| Resistance Level | $6.96 | $0.31 |
| Average True Range (ATR) | 1.32 | 0.06 |
| MACD | -0.38 | -0.00 |
| Stochastic Oscillator | 25.17 | 6.95 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.